Medicare and Dental Coverage: A Closer Look
(By Meredith Freed, Nancy Ochieng, Nolan Sroczynski, Anthony Damico, and Krutika Amin for Kaiser Family Foundation published July 28, 2021)
Read More
Legislative Update
How drug pricing proposals would lower costs
A recent survey found 80 percent of American adults believe prescription drugs are unreasonably expensive, and almost 90 percent of
Read MoreRepresentatives introduce Medicare dental coverage bill
(By Nick Moran for Becker’s Hospital Review) Reps. Steven Horsford, D-Nev. and Robin Kelly, D-Ill., co-authored a bill that would
Read MoreAdding dental, vision and hearing to Medicare will be costly, but worth it
The Congressional Democrats are expected to submit a bill containing a provision to expand traditional Medicare later this year. The
Read MoreCalifornia Makes It Easier for Low-Income Residents to Get and Keep Free Health Coverage
(By Rachel Bluth for Kaiser Health News) SACRAMENTO, Calif. — Getting clean drinking water cost Ignacio Padilla his health insurance.
Read MoreBiden’s July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough?
(By Victoria Knight for Kaiser Health News) President Joe Biden’s executive order of July 9 included various steps toward making
Read MoreSenate Democrats’ Plan Boosts Spending on Medicare, ACA Subsidies, Long-Term Care
(By Michael McAuliff for Kaiser Health News) The budget package Democrats are assembling in Congress would likely provide the biggest
Read MoreMedicare expansion included in Senate Democrats’ $3.5 trillion spending framework: 5 things to know
(By Molly Gamble for Becker’s Hospital Review) Senate Democrats on July 13 reached an agreement to pursue a $3.5 trillion
Read MoreWhy the pharmaceutical industry has ‘mixed views’ on Biden’s latest executive order
(By Katie Adams for Becker’s Hospital Review) The American Pharmacists Association “has mixed views” on the executive order President Joe
Read MoreDrugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
(By Michael McAuliff for Kaiser Health News) The largest drug companies are far more interested in enriching themselves and investors
Read More